Close

Vanda Pharma (VNDA) Completes Tasimelteon pre-NDA with FDA Unit

March 25, 2013 6:57 AM EDT Send to a Friend
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the company held a pre-NDA meeting with the Division of Neurology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login